Efficacy, Safety and Health-related Quality of Life of Repeat OnabotulinumtoxinA for OAB and UI - David Sussman
November 19, 2014
Interim Analysis of Long-term Efficacy, Safety and Health-related Quality of Life of Repeat OnabotulinumtoxinA in the Treatment of Overactive Bladder and Urinary Incontinence
David O. Sussman, DO, FACOS
Clinical Associate Professor, Department of Surgery
Division of Urology, Rowan University
Section Head, Female Urology and Voiding Dysfunction
Chief of Urology, Kennedy Health System
David O Sussman, DO, FACOS, is clinical associate professor in the Department of Surgery, Division of Urology, and section head of Female Urology and Voiding Dysfunction at Rowan University. He also serves as chief of urology for the Kennedy Health System, a 3 hospital health system in southern New Jersey. Dr. Sussman received his medical degree in 1985 from the University of New England in Biddeford, Maine, and completed his residency in general surgery and urology at UMDNJ and the Kennedy Memorial Hospitals-University Medical Center in Stratford. He also participated in a fellowship program in female urology and voiding dysfunction with Gary Leach, MD, at Kaiser Permanente in Los Angeles, California.
Dr. Sussman has lectured and published in peer-reviewed journals on the subjects of overactive bladder (OAB), urinary incontinence, voiding dysfunction, benign prostatic hyperplasia (BPH), and erectile dysfunction. He is a board-certified urologic surgeon and a fellow of American College of Osteopathic Surgeons (FACOS), and is a member of numerous professional associations, including the, the American Urological Association, ACOS, the International Continence Society, and the Society for Urodynamics and Female Urology.
Dr. Sussman is actively engaged in clinical research involving BPH, urinary incontinence and voiding dysfunction. Current studies include the use of botulinum toxin type A and the combination of an antimuscarinic agent and alpha-blocker in men with OAB.
Dr. Sussman has served as a speaker, moderator, and symposium chairman for many major urology symposia, seminars and conferences, lectured nationally and internationally on the evaluation and treatment of OAB/incontinence, and has authored or co-authored many respected journal articles, posters and abstracts. He was recently named as an editorial board member of Reviews in Urology.